Clinical Trials Directory

Trials / Terminated

TerminatedNCT00480948

Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants

Effects of InFat™ Product (High Sn-2 Palmitic Acid) on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants: a Triple-blind, Randomized, Placebo-controlled Trial

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Enzymotec · Industry
Sex
All
Age
1 Day – 8 Days
Healthy volunteers
Accepted

Summary

The purpose of this study is to demonstrate the efficacy of infant formula having proportion of palmitate in the sn-2 position comparable to human milk in Chinese term infants.

Detailed description

In human breast milk, and in most infant formulas more than 98% of this milk fat is in the form of triglycerides, which contain saturated and unsaturated fatty acids esterified to glycerol. Fatty acids in human milk-fat have a highly specific positional distribution on the glycerol backbone and this specific configuration is known to have a major contribution to the efficacy of this nutrient absorption. Palmitic acid (C16:0), the major saturated fatty acid, is predominantly esterified to the sn-2 (β) position of the triglyceride in human milk. In contrast, palmitic acid in standard infant formulas is esterified to the sn-1 and sn-3 positions. Infants fed with high sn-2 palmitic acid formula had softer stools, less constipation and better calcium absorption as compared to standard infant formula. InFat™ is structured triglyceride fat ingredient with high levels of palmitic acid at sn-2 position. The primary objective of this trial is to demonstrate that feeding Chinese term infants, with formula having proportion of palmitate in the sn-2 position comparable to human milk, reduces calcium-soaps formation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInfant formula feeding (InFat™)Infant formula with InFat™ oil (containing \~49% of C16:0 at sn-2 position), 24 wk
DIETARY_SUPPLEMENTControlStandard vegetable oil based infant formula

Timeline

Start date
2008-09-01
Primary completion
2009-04-01
Completion
2009-08-01
First posted
2007-05-31
Last updated
2011-06-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00480948. Inclusion in this directory is not an endorsement.